Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05116397 · ClinicalTrials.gov registry record · NA

Influence of Graded Hypercapnia on Endurance Exercise Performance

A NA study, sponsored by United States Army Research Institute of Environmental Medicine.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT05116397: Completed NA study, sponsored by United States Army Research Institute of Environmental Medicine.

NCT05116397 is a NA study that has completed, run by United States Army Research Institute of Environmental Medicine. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05116397, a NA study, has completed, sponsored by United States Army Research Institute of Environmental Medicine.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

The aim of this randomized, single-blind, placebo-controlled crossover trial is to determine the effects of graded hypercapnia (0, 2, and 4% inspired CO2) on endurance performance. Twelve healthy and fit young adults (men and women) will complete this study. Participants will perform experimental trials on 3 separate days (one each breathing 0%, 2%, and 4% inspired CO2-all with normal 21% oxygen). During each trial, they will perform 10 minutes of submaximal treadmill walking exercise and then complete a self-paced 2-mile treadmill run time-trial.

Primary Outcome

Time to complete self-paced 2 mile treadmill time trial (min:sec)

Interventions

  • OTHER Inspired gas

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2021-09-10
Est. Completion 2022-04-14
Phase NA

What the finished NCT05116397 record still lists

NCT05116397 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Inspired gas is the first listed.

NCT05116397 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05116397 about?

NCT05116397 is a clinical study titled "Influence of Graded Hypercapnia on Endurance Exercise Performance". The aim of this randomized, single-blind, placebo-controlled crossover trial is to determine the effects of graded hypercapnia (0, 2, and 4% inspired CO2) on endurance performance. Twelve healthy and fit young adults (men and women) will complete this study. Participants will perform experimental tr...

What is the current status of trial NCT05116397?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2021-09-10. Estimated completion is 2022-04-14.

What interventions are being tested in trial NCT05116397?

The interventions under investigation include: Inspired gas (OTHER).

Who is sponsoring clinical trial NCT05116397?

This trial is sponsored by United States Army Research Institute of Environmental Medicine, which has 59 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05116397's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05116397, the US trial registry maintained by the National Library of Medicine. NCT05116397 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.